FDA Approves Pill Version of Wegovy
Novo Nordisk’s semaglutide will soon be available in a daily pill Americans can take for weight loss.
Brain Gear Is the Hot New Wearable
Smartwatches are cool and all, but have you considered wearable neurotech?
Sam Altman’s New Brain Venture, Merge Labs, Will Spin Out of a Nonprofit
Merge Labs, a brain-computer interface startup that seeks to read brain activity using ultrasound, is being spun out of Forest Neurotech, a Los Angeles nonprofit.
Former Neuralink Exec Launches Organ Preservation Effort
Science Corporation, founded by Neuralink’s first president, Max Hodak, has unveiled a prototype machine to extend the life of organs for longer periods.
RFK Jr.’s Health Department Is Pondering a National Men’s Health Initiative
At an FDA discussion of testosterone replacement therapy, a top official called for special health centers to address a “men’s health crisis.” Others called to ease men’s access to hormones.
Many States Say They’ll Defy RFK Jr.’s Changes to Hepatitis B Vaccination
Most Democratic-led states will continue to recommend the hepatitis B vaccine at birth, despite a CDC advisory panel’s vote against it.
A Fentanyl Vaccine Is About to Get Its First Major Test
ARMR Sciences of New York is trialing a vaccine in the Netherlands to protect against fentanyl-related overdose and death.
Paradromics Gets FDA Approval to Trial Its Brain Implant in People
The Austin-based startup will test its high-bandwidth device to help restore speech in people with extremely limited movement.
Weight-Loss Drug Zepbound Is Being Tested as a Treatment for Long Covid
GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid.
A Gene Editing Therapy Cut Cholesterol Levels by Half
An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.